Thrice weekly warfarin administration in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 10, 2009, Pages 3162-3167

  Sood, Manish M ^a,b,c   Rigatto, Claudio ^a,b,c   Bueti, Joe ^b,c,d   Lang, Cory ^a,b   Miller, Lisa ^b,c,d   Ponnampalam, Arjuna ^b   Reslerova, Martina ^a,b,c   Sood, Amy ^a,b,c   Komenda, Paul ^a,b,c  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Manitoba Renal Program   (Canada)

^d HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bleeding events; End stage renal disease; Haemodialysis; Warfarin

Indexed keywords

WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BREAST DISEASE; CANADA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG FATALITY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PHARYNX HEMORRHAGE; PILOT STUDY; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE;

AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PILOT PROJECTS; RENAL DIALYSIS; WARFARIN;

EID: 70349484208     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp252     Document Type: Article

References (21)

1. Saran R, Dykstra D, Wolfe R et al. Association between vascular access failure and the use of specific drugs: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2002; 40: 1255-1263 (Pubitemid 35403138)
2. Holden R, Booth SL. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 105-110
3. Elliott MJ, Zimmerman D, Holden RM. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. Am J Kidney Dis 2007; 50: 433-440
4. Hall AM, Wilkins MR. Warfarin: a case history in pharmacogenetics. Heart 2005; 91: 563-564
5. Phillips KW, Dobesh PP, Haines ST. Considerations in using anticoagulant therapy in special patient populations. Am J Health Syst Pharm 2008; 65: s13-s21
6. Amanzadeh J, Reilly FR Jr. Anticoagulation and continuous renal replacement therapy. Semin Dial 2006; 19: 311-316
7. Ansell J, Hirsh J, Hylek E et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). CHEST 2008; 160S-198S (Pubitemid 351892967)
8. Denhaerynck K, Manhaeve D, Dobbels F et al. Prevalence and consequences of nonadherence to hemodialysis regimens. Am J Crit Care 2007; 16: 222-235
9. Agarwal R, Lewis R, Davis J et al. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. Am J Kidney Dis 2001; 38: 1245-1250
10. Agarwal R. Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int 1999; 55: 1528-1535
11. Hemmelgarn B, Manns B, Quan H et al. Adapting the Charlson co-morbidity index for use in patients with ESRD.Am J Kidney Dis 2003; 42: 125-132
12. Leggat JE. Adherence with dialysis: a focus on mortality risk. Semin Dial 2005; 18: 137-141
13. Karamanidou C, Clatworthy J, Weinman J et al. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 2008; 9: 2
14. Kimmel PL, Varela MP, Peterson RA et al. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus. Kidney Int 2000; 57: 1141-1151
15. Saran R, Bragg-Gresham JL, Rayner HC et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 2003; 64: 254-262
16. Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet 2005; 44: 1227-1246
17. Staresinic AG, Sorkness CA, Goodman BM et al. Comparison of outcomes using 2 delivery models of anticoagulation care. Arch Intern Med 2006; 166: 997-1002
18. Cham FWH, Wong RSM, Lau W et al. Management of Chinese patients on warfarin therapy in two models of anticoagulation service: a prospective randomized trial. Br J Clin Pharmacol 2006; 62: 601-609
19. Bennett WM. Should dialysis patients ever receive warfarin and for what reasons? Clin J Am Soc Nephrol 2006; 1: 1357-1359
20. Pilkey RM, Morton RA, Boffa MB et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007; 49: 432-439
21. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006; 19: 317-322